4Avranmis VI,Sencer S,Periclou AP,et al.A randomized comparison of native Escherichia Coli as paraginase for treatment of children wth newly diagnosed stand-risk acute lymphoblastic leukemia:a chidren's cancer group study[J].Blood,2002,99(6):1986.
5Kurre HA,Ettinger AG,Veenstra DL,et al.A pharmaconomic anal ysis of pegaspargase versus native escherickia coli lasparaginase for treatment of children with standard risk actute lymphoblastic leukemia:the children's cancer group study(CCG1962)[J].J Pediatr Hematol Oncol,2002,24(3):175.
6Lo CF,Zelem A,Kimchi A,et al.Progress indifferentiation induction as a treatment for acute promylocytic leukemia and beyond[J].Cancer Res,2002,62(19):5618.
7Kantarjian HM.Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia[J].Blood,2002,100(95):1590.
8Kell LM,Yu JC,Boulton CL,et al.CT53518,novel selective FLT3 an tagonist for the treatment of acute myelogenous leukemia (AML)[J].Cancer Cell,2002,1(5):421.
